Two Sigma Securities’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Two Sigma Securities’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-60,102	Closed	-$14.8K	–	2291
2026 Q1	$14.8K	Buy	60,102 +42,480	+241%	+$16.9K	﹤0.01%	1422
2025 Q4	$7.4K	Sell	17,622 -47,690	-73%	-$25.3K	﹤0.01%	1317
2025 Q3	$44K	Buy	+65,312	New	+$35.2K	0.01%	1007
2020 Q1	–	Sell	-16,528	Closed	-$138K	–	2184
2019 Q4	$138K	Buy	+16,528	New	+$152K	﹤0.01%	2166
2019 Q3	–	Sell	-16,471	Closed	-$177K	–	2413
2019 Q2	$177K	Buy	+16,471	New	+$175K	﹤0.01%	1767
2017 Q1	–	Sell	-21,733	Closed	-$66K	–	1093
2016 Q4	$66K	Buy	+21,733	New	+$79.1K	0.02%	587

Other funds holding SGMO

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

AIM

Axiom Investment Management New York $150M AUM

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Two Sigma Securities's SGMO Position: Q2 2026 in Review

Two Sigma Securities sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 60,102 shares — an estimated $14.8K sold.

Two Sigma Securities first reported a position in SGMO in Q4 2016 and held it in 6 quarters. The position peaked at $177K in Q2 2019. 6 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Two Sigma Securities reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
Two Sigma Securities sold 60,102 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $14.8K.
Two Sigma Securities first reported a position in SANGAMO THERAPEUTICS INC in Q4 2016 and held it in 6 quarters.
Two Sigma Securities's SANGAMO THERAPEUTICS INC position peaked at $177K in Q2 2019.
6 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.